PPD Development is a clinical research site located in Wilmington, North Carolina, United States 28401-3331.
Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.
PPD Development has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment, Leukemia, Myelodysplastic Syndromes.
Sponsors: AbbVie, Roswell Park Cancer Institute, Glaxo Wellcome.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Wilmington
Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
PPD Development has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
PPD Development has 5 clinical trials on record, with 1 currently active. Their work covers Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment, Leukemia, Myelodysplastic Syndromes.
PPD Development has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.